India
Dermatology · 4 min read

Localized epidermolysis bullosa simplex

Learn about Localized epidermolysis bullosa simplex, its reported features, relevant specialists, and questions to discuss at a medical consultation.

Also known as: EBS-loc; Epidermolysis bullosa simplex of palms and soles; Epidermolysis bullosa simplex, Weber-Cockayne type; Localized EBS

Compiled from public sources
Text selected and arranged from Orphanet. It describes the condition as those sources do; it has not been rewritten for India.
01 Oct 2026
Not medically reviewed
No registered doctor has reviewed this page. Use it to decide who to see and what to ask — not to diagnose or treat.
—
This is not medical advice. If symptoms are severe, sudden or getting worse, call 112 (or 108 for an ambulance) or go to the nearest emergency department.

The sources compiled here do not cover: diagnosis, treatment, prevention, prognosis, prevalence. Ask the treating doctor about these.

What it is

From: Orphanet

Localized epidermolysis bullosa simplex, formerly known as EBS, Weber-Cockayne, is a basal subtype of epidermolysis bullosa simplex (EBS). The disease is characterized by blisters occurring mainly on the palms and soles, exacerbated by warm weather.

Reported clinical features and what the terms mean

The following findings are associated with this condition in Orphanet. They are not a checklist for diagnosing yourself, and they do not all occur in every affected person. Some are examination, imaging or laboratory findings that cannot be recognised at home.

The frequency labels describe how often a finding was reported among people with the condition in the source. They do not give the chance that a person with that symptom has the condition. Definitions below reproduce HPO terminology; they explain the term, not the likely severity in an individual.

Abnormal blistering of the skin · Very frequent (99-80%)
The presence of one or more bullae on the skin, defined as fluid-filled blisters more than 5 mm in diameter with thin walls.
Focal friction-related palmoplantar hyperkeratosis · Very frequent (99-80%)
Hyperkeratosis affecting the palm of the hand and the sole of the foot in areas exposed to friction.
Foot pain · Very frequent (99-80%)
An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the foot.
Junctional split · Very frequent (99-80%)
The formation of bullae (blisters) with cleavage in the lamina lucida layer of the skin.
Palmoplantar blistering · Very frequent (99-80%)
A type of blistering that affects the skin of the palms of the hands and the soles of the feet.
Pruritus · Very frequent (99-80%)
Pruritus is an itch or a sensation that makes a person want to scratch. This term refers to an abnormally increased disposition to experience pruritus.
Skin fragility with non-scarring blistering · Very frequent (99-80%)
Heat intolerance · Frequent (79-30%)
The inability to maintain a comfortable body temperature in warm or hot weather.
Paresthesia · Frequent (79-30%)
Abnormal sensations such as tingling, pricking, or numbness of the skin with no apparent physical cause.
Skin plaque · Frequent (79-30%)
A plaque is a solid, raised, plateau-like (flat-topped) lesion greater than 1 cm in diameter.
Upper limb pain · Frequent (79-30%)
An unpleasant sensation characterized by physical discomfort (such as pricking, throbbing, or aching) localized to the arm.
Acute episodes of neuropathic symptoms · Frequent (79-30%)
Erosion of oral mucosa · Occasional (29-5%)
Loss of the superficial layer of the oral mucosa usually resulting in a shallow or crusted lesion.
Hyperhidrosis · Occasional (29-5%)
Abnormal excessive perspiration (sweating) despite the lack of appropriate stimuli like hot and humid weather.

Other findings in the same source

From: Orphanet

Additional reported features include Palmar hyperkeratosis (Occasional (29-5%)); Plantar hyperkeratosis (Occasional (29-5%)); Skin erosion (Occasional (29-5%)); Atrophic scars (Very rare (<4-1%)); Erythematous papule (Very rare (<4-1%)); Milia (Very rare (<4-1%)); Nail dystrophy (Very rare (<4-1%)); Oral mucosal blisters (Very rare (<4-1%)). This is a selected summary, not a complete description of the condition.

When it may begin

From: Orphanet

Childhood

Inheritance in the source

From: Orphanet

Autosomal dominant

Understanding the inheritance label

From: MedlinePlus Genetics

An autosomal dominant pattern means that one altered copy of a relevant gene can be sufficient for the condition. Some affected people inherit the change; others have a new change without an affected parent. The precise finding, family history and condition determine what this means for relatives.

Which doctor should you see?

The suggested department for discussing Localized epidermolysis bullosa simplex is Dermatology, with a dermatologist as the relevant type of clinician. Dermatologist; paediatric services for children as appropriate.

Additional services that may be relevant, depending on the findings, include: Clinical Genetics.

This is an editorial referral starting point. The appropriate clinic depends on the person’s age, symptoms, previous diagnosis and local services. The first clinician can decide whether another specialty or a team is needed; a department label does not confirm the diagnosis.

How to prepare for an assessment

Bring a short timeline of the main symptoms: when they first appeared, whether they are constant or episodic, what seems to change them, and how they affect daily activities. Include previous reports, discharge summaries, current medicines and supplements, allergies, and any relevant family history. A dated record is more useful than trying to match every feature in an online article.

Ask the clinician what is already established and what remains uncertain. If a test is suggested, ask what question it answers, what its limitations are and how the result would change the next step. The information here is not an instruction to arrange every possible test. In children, bring growth, developmental and school information if it is relevant to the concern.

  • Which features of the skin, hair or nails distinguish the possibilities?
  • Would photographs over time help document the changes?
  • What should be expected from treatment, and how will irritation or other adverse effects be managed?

Treatment discussions and follow-up

The material gathered for this draft does not provide a complete condition-specific treatment pathway for Localized epidermolysis bullosa simplex. That gap does not mean that treatment is unavailable. A clinician needs to establish the diagnosis and review current guidance before recommending medicines, procedures, rehabilitation or other support.

Before leaving the appointment, clarify the next review date, who will communicate results, and whom to contact if the situation changes. Discuss difficulties with sleep, work, school, mobility, eating or emotional wellbeing when these are relevant. Practical support may require coordination between the treating clinician and other services.

The collected references do not establish a complete prevention or long-term outlook section for this entry. Missing information should not be interpreted as proof that prevention is impossible or that a particular outcome is inevitable. Ask what is known for the exact subtype, stage and personal circumstances, and which uncertainties remain.

When to seek emergency help

Severe breathing difficulty, collapse, new stroke-like symptoms, a seizure that is prolonged or repeated without recovery, uncontrolled major bleeding, or an immediate risk of self-harm require emergency help. In India, call 112 or reach the nearest emergency department. This is a general, non-exhaustive warning list; it is not a condition-specific triage tool.

Find a doctor for Localized epidermolysis bullosa simplex

This condition is usually assessed by a dermatologist. Every profile shows the doctor’s registration and what has been checked.

All dermatology conditions →

Sources

Source: MedlinePlus, National Library of Medicine. Orphadata Science: Free access data from Orphanet. © INSERM 1999; July 2026 data, CC BY 4.0. This product uses the Human Phenotype Ontology (hp/releases/2026-09-01). Only sources listed for this article apply. Source material has been selected and arranged; HPO definitions are reproduced without alteration. No source organisation endorses this compilation. Köhler S et al. The Human Phenotype Ontology project: linking molecular biology and disease through phenotype data. Nucleic Acids Research 2014;42(D1):D966–D974. doi:10.1093/nar/gkt1026.

General information, not advice about your situation. Errors can be reported through the corrections process. Reference TDI-C-1436.